Mutational spectrum of Smith–Lemli–Opitz syndrome

Smith–Lemli–Opitz syndrome (SLOS; OMIM #270400) is an autosomal recessive malformation syndrome characterized by a large spectrum of morphogenic and congenital anomalies. SLOS is caused by mutations in the DHCR7 gene, which encodes 7‐dehydrocholesterol reductase, the enzyme that catalyzes the final step in cholesterol biosynthesis. We report on 154 currently known mutations in DHCR7 identified in patients affected with SLOS and discuss their coding consequences. These 154 mutations include 130 missense, 8 nonsense, 8 deletions, 2 insertions, 1 indel, and 5 splice site mutations. Using information available from published case reports and from patients identified in our clinical diagnostic laboratory, we analyzed correlations between genotype, clinical presentation and 7‐dehydrocholesterol level. © 2012 Wiley Periodicals, Inc.

[1]  J. Al-Aama,et al.  Smith–Lemli–Opitz syndrome among Arabs , 2012, Clinical genetics.

[2]  Leslie G Biesecker,et al.  Next‐generation sequencing demands next‐generation phenotyping , 2012, Human mutation.

[3]  D. Gaudet,et al.  ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia , 2012, Epigenetics.

[4]  Y. Ville,et al.  Phenotypic spectrum of fetal Smith-Lemli-Opitz syndrome. , 2012, European journal of medical genetics.

[5]  C. Argmann,et al.  New Driver for Lipid Synthesis , 2011, Cell.

[6]  F. Porter,et al.  Discordant phenotype and sterol biochemistry in Smith–Lemli–Opitz syndrome , 2010, American journal of medical genetics. Part A.

[7]  Aleksandra Jezela-Stanek,et al.  Differences between predicted and established diagnoses of Smith-Lemli-Opitz syndrome in the Polish population: underdiagnosis or loss of affected fetuses? , 2010, Journal of Inherited Metabolic Disease.

[8]  M. Muenke,et al.  Cyclopia (synophthalmia) in Smith–Lemli–Opitz syndrome: First reported case and consideration of mechanism , 2010, American journal of medical genetics. Part C, Seminars in medical genetics.

[9]  E. Tierney,et al.  Analysis of short‐term behavioral effects of dietary cholesterol supplementation in Smith–Lemli–Opitz syndrome , 2010, American journal of medical genetics. Part A.

[10]  C. Ki,et al.  A Novel DHCR7 Mutation in a Smith-Lemli-Opitz Syndrome Infant Presenting with Neonatal Cholestasis , 2009, Journal of Korean medical science.

[11]  A. Jezela-Stanek,et al.  Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature. , 2008, European journal of medical genetics.

[12]  C. Ki,et al.  Identification of a Novel DHCR7 Mutation in a Korean Patient With Smith-Lemli-Opitz Syndrome , 2007, Journal of child neurology.

[13]  L. Kozák,et al.  Molecular screening of Smith–Lemli–Opitz syndrome in pregnant women from the Czech Republic , 2007, Journal of Inherited Metabolic Disease.

[14]  B. Eng,et al.  Prenatal diagnosis of Smith‐Lemli‐Opitz syndrome (SLOS) by DHCR7 mutation analysis , 2007, Prenatal diagnosis.

[15]  Y. Yamauchi,et al.  Cholesterol sensing, trafficking, and esterification. , 2006, Annual review of cell and developmental biology.

[16]  H. Waterham.  Defects of cholesterol biosynthesis , 2006, FEBS letters.

[17]  G. Seth,et al.  Reverting cholesterol auxotrophy of NS0 cells by altering epigenetic gene silencing. , 2006, Biotechnology and bioengineering.

[18]  R. Azurdia,et al.  Photosensitive Smith–Lemli–Opitz syndrome is not caused by a single gene mutation: analysis of the gene encoding 7‐dehydrocholesterol reductase in five U.K. families , 2005, The British journal of dermatology.

[19]  F. Porter,et al.  DHCR7 mutations in Brazilian Smith–Lemli–Opitz syndrome patients , 2005, American journal of medical genetics. Part A.

[20]  F. Santorelli,et al.  Molecular studies in Portuguese patients with Smith-Lemli-Opitz syndrome and report of three new mutations in DHCR7. , 2005, Molecular genetics and metabolism.

[21]  K. Morishima,et al.  R352Q mutation of the DHCR7 gene is common among Japanese Smith-Lemli-Opitz syndrome patients , 2005, Journal of Human Genetics.

[22]  M. Nowaczyk,et al.  Identification of nine novel DHCR7 missense mutations in patients with Smith‐Lemli‐Opitz syndrome (SLOS) , 2005, Human mutation.

[23]  R. Steiner,et al.  DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome , 2005, Journal of Medical Genetics.

[24]  P. Clayton,et al.  Identification of 14 novel mutations in DHCR7 causing the Smith‐Lemli‐Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy , 2005, Human mutation.

[25]  A. Jezela-Stanek,et al.  DHCR7 mutations and genotype–phenotype correlation in 37 Polish patients with Smith–Lemli–Opitz syndrome , 2004, Clinical genetics.

[26]  Brian C. Battaile,et al.  Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome. , 2004, Molecular genetics and metabolism.

[27]  P. Clayton,et al.  Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome , 2004, Journal of Medical Genetics.

[28]  M. Nowaczyk,et al.  Founder effect for the T93M DHCR7 mutation in Smith‐Lemli‐Opitz syndrome , 2004, American journal of medical genetics. Part A.

[29]  K. Antshel,et al.  Normal cognition and behavior in a Smith‐Lemli‐Opitz syndrome patient who presented with Hirschsprung disease , 2003, American journal of medical genetics. Part A.

[30]  Ronald J A Wanders,et al.  Identification of three patients with a very mild form of Smith‐Lemli‐Opitz syndrome , 2003, American journal of medical genetics. Part A.

[31]  M. Digilio,et al.  Two novel mutations of the human Δ7-sterol reductase (DHCR7) gene in children with Smith–Lemli–Opitz syndrome , 2002 .

[32]  G. Utermann,et al.  Novel mutation in the Delta-sterol reductase gene in three Lebanese sibs with Smith-Lemli-Opitz (RSH) syndrome. , 2002, American journal of medical genetics.

[33]  D. Chitayat,et al.  Smith-Lemli-Opitz syndrome: carrier frequency and spectrum of DHCR7 mutations in Canada , 2002, Journal of medical genetics.

[34]  M. Nowaczyk,et al.  Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype. , 2002, American journal of medical genetics.

[35]  M. Nowaczyk,et al.  DHCR7 and Smith-Lemli-Opitz syndrome. , 2001, Clinical and investigative medicine. Medecine clinique et experimentale.

[36]  I. Glass,et al.  Novel mutation in the Δ7‐dehydrocholesterol reductase gene in an Australian patient with Smith‐Lemli‐Opitz syndrome , 2001 .

[37]  M. Nowaczyk,et al.  Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome. , 2001, American journal of medical genetics.

[38]  R. Hennekam,et al.  Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith--Lemli--Opitz syndrome. , 2001, Annals of human genetics.

[39]  G. Utermann,et al.  Mutations in the human DHCR7 gene , 2001, Human mutation.

[40]  H. Waterham,et al.  Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. , 2000, Biochimica et biophysica acta.

[41]  G. Utermann,et al.  Homozygosity for the W151X stop mutation in the delta7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: retrospective molecular diagnosis. , 2000, American journal of medical genetics.

[42]  C. Maslen,et al.  Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping. , 2000, American journal of medical genetics.

[43]  Hongwei Yu,et al.  Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome. , 2000, Human molecular genetics.

[44]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of medical genetics.

[45]  R. Carrozzo,et al.  Novel 7-DHCR mutation in a child with Smith-Lemli-Opitz syndrome. , 2000, American journal of medical genetics.

[46]  U. Seedorf,et al.  Mutational Spectrum in the Δ7-Sterol Reductase Gene and Genotype-Phenotype Correlation in 84 Patients with Smith-Lemli-Opitz Syndrome , 2000 .

[47]  A. Ciccodicola,et al.  Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutations , 1999, European Journal of Human Genetics.

[48]  D. Neklason,et al.  Biochemical variants of Smith-Lemli-Opitz syndrome. , 1999, American journal of medical genetics.

[49]  D T Whelan,et al.  Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. , 1998, American journal of medical genetics.

[50]  P. Vreken,et al.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. , 1998, American journal of human genetics.

[51]  G. Utermann,et al.  Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. S. Lin,et al.  Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. , 1998, American journal of human genetics.

[53]  K. Mills,et al.  Prenatal diagnosis of Smith-Lemli-Opitz syndrome. , 1995, American journal of medical genetics.

[54]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[55]  J. Opitz,et al.  Female external genitalia and müllerian duct derivatives in a 46,XY infant with the smith-lemli-Opitz syndrome. , 1987, American journal of medical genetics.

[56]  J. Opitz,et al.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES. , 1964, The Journal of pediatrics.

[57]  D. Noto,et al.  A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome , 2012, Molecular Diagnosis.

[58]  L. Kozák,et al.  A patient with Smith–Lemli–Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement , 2009, European Journal of Pediatrics.

[59]  V. Cormier-Daire,et al.  Circonstances cliniques du diagnostic du syndrome de Smith-Lemli-Opitz et tentatives de corrélation phénotype-génotype : à propos de 45 cas , 2003 .

[60]  F. Chevy,et al.  [Clinical characteristics and diagnosis of Smith-Lemli-Opitz syndrome and tentative phenotype-genotype correlation: report of 45 cases]. , 2003, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[61]  U. Seedorf,et al.  Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations , 2001, European Journal of Human Genetics.

[62]  I. Glass,et al.  Novel mutation in the Delta7-dehydrocholesterol reductase gene in an Australian patient with Smith-Lemli-Opitz syndrome. , 2001, American journal of medical genetics.